Search Results

Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy.

• Authors : Pan S; Chinese People's Liberation Army (PLA) Medical School, Beijing, China.; Department of Infectious Diseases, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Subjects: Hepatitis B*/Hepatitis B*/Hepatitis B*/complications ; Hepatitis B*/Hepatitis B*/Hepatitis B*/drug therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy

• Source: Frontiers in immunology [Front Immunol] 2022 May 25; Vol. 13, pp. 892618. Date of Electronic Publication: 2022 May 25 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Examining Liver Cancer Patients and a High-Risk Group in a Vulnerable Area: An Experience from the Ulleung Liver Cancer Prevention and Management Project.

• Authors : Ryu DH; Department of Preventive Medicine, Catholic University of Daegu School of Medicine, Daegu 42472, Korea.; Lee YM

Subjects: Carcinoma, Hepatocellular* ; Hepatitis B*/Hepatitis B*/Hepatitis B*/epidemiology ; Hepatitis B*/Hepatitis B*/Hepatitis B*/prevention & control

• Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Oct 23; Vol. 17 (21). Date of Electronic Publication: 2020 Oct 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601

Record details

Seroprevalence of hepatitis B surface antigenemia and viral infectivity among liver cancer patients accessing care at a tertiary health facility in Southwest Nigeria.

• Authors : Bakarey AS; a Medical Virology Unit, Institute for Advanced Medical Research & Training , College of Medicine, University of Ibadan , Ibadan , Nigeria.; Jabaru O

Subjects: Health Facilities*; Hepatitis B/Hepatitis B/Hepatitis B/*immunology ; Hepatitis B Surface Antigens/Hepatitis B Surface Antigens/Hepatitis B Surface Antigens/*immunology

• Source: Journal of immunoassay & immunochemistry [J Immunoassay Immunochem] 2018; Vol. 39 (2), pp. 196-206. Date of Electronic Publication: 2018 May 17.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100963688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Construction of an immune-related prognostic model to predict prognosis and immunotherapy in liver cancer patients with hepatitis B virus-infected.

• Authors : Nan Dong; Chen Fu

Subjects: PROGNOSTIC models; HEPATITIS B; LIVER cancer

• Source: Medical Data Mining; 2024, Vol. 7 Issue 1, p1-8, 8p

Record details

Agricola

Record details

Efficacy evaluation and prognostic risk factors analysis of precise hepatectomy in the treatment of intermediate and advanced hepatocellular carcinoma.

• Authors : Zhang J; Department of Hepatobiliary Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China.; Zeng Q

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/surgery ; Hepatitis B*

• Source: European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2023 Jan 01; Vol. 35 (1), pp. 120-126. Date of Electronic Publication: 2022 Nov 17.Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9000874 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019.

• Authors : Ajuwon BI; Research School of Population Health, ANU College of Health and Medicine, The Australian National University, Acton, ACT, Australia. .; Department of Biosciences and Biotechnology, Faculty of Pure and Applied Sciences, Kwara State University, Malete, Nigeria. .

Subjects: Hepatitis B*/Hepatitis B*/Hepatitis B*/epidemiology ; Hepatitis B virus*; Hepatitis B Surface Antigens

• Source: BMC infectious diseases [BMC Infect Dis] 2021 Oct 30; Vol. 21 (1), pp. 1120. Date of Electronic Publication: 2021 Oct 30.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.

• Authors : Ken Shirabe; Toru Ikegami; Tomoharu Yoshizumi

Subjects: HEPATITIS B; LIVER cancer patients; LIVER cancer -- Etiology

• Source: Annals of Hepatology: Official Journal of the Mexican Association of Hepatology; Jul/Aug2018, Vol. 17 Issue 4, p596-603, 8p

Record details

Clinical significance of serum sB7-H3 and IL-1 in patients with hepatitis B related hepatocellular carcinoma.

• Authors : Feng Dai; Shou-zhong Fu; Bin Wang

Subjects: SERUM; INTERLEUKIN-1; HEPATITIS B

• Source: Journal of Hainan Medical University; Oct2019, Vol. 25 Issue 19, p57-61, 5p

Record details

New Hepatitis B Virus Study Findings Have Been Reported by Researchers at Second Hospital of Nanjing (Diagnostic value of combined detection of abnormal prothrombin and other two indicators in AFP-negative primary liver cancer patients).

Subjects: HEPATITIS B virus; CANCER patients; PROTHROMBINNANJING (Jiangsu Sheng, China)

• Source: Hepatitis Weekly; 10/9/2023, p218-218, 1p

Record details